title: Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy.
abstract: OBJECTIVE
  In the absence of other causes, obesity increases the risk of liver disease. We evaluated the prevalence and degree of metabolic and hepatic abnormalities associated with non-alcoholic fatty liver disease (NAFLD) in type II-III obesity in a metropolitan area of South Italy.
  
  
  METHODS
  187 (81 M, 106 F) young adult non-diabetic obese patients, age range 18-50 years (mean 31.9 +/- 8.8), body mass index (BMI) > or =30 (mean 47.5 +/- 9.6), consecutively admitted from January 2000 to April 2003 to the Obesity Outpatients Clinic entered into the study. Patients were divided into two groups: (1) BMI 30.0-39.9, and (2) BMI> or =40. Ultrasound detected liver steatosis was classified as: (I) mild; (II) moderate, and (III) severe.
  
  
  RESULTS
  All patients, except 4, showed a variable degree of steatosis: mild was more frequent among females, severe steatosis present only in grade III obesity, with higher prevalence in males than in females (p < 0.001). Mean serum transaminases, in particular alanine aminotransferase (ALT), increased according to BMI and degree of steatosis. Homeostasis Model Assessment (HOMA) index, ferritin and fibrinogen levels increased with BMI, particularly in severe steatosis. In group 2, patients with BMI> or =40 showed a positive correlation between ferritin, aspartate aminotransferase (AST) (r = 0.46, p < 0.018), ALT (r = 0.41, p < 0.036) and gamma-glutamyltransferase (gammaGT) (r = 0.51, p < 0.007), between serum triglycerides (TG) and AST (r = 0.28, p < 0.036), ALT (r = 0.30, p < 0.02) and between HOMA and ALT (r = 0.30, p < 0.03) and gammaGT (r = 0.35, p < 0.012). In group 2 patients with severe steatosis the prevalence of metabolic syndrome according to Adult Treatment Panel III (ATP III) was 40%.
  
  
  CONCLUSIONS
  These data suggest that, in young adult non-diabetic grade III obese patients, fatty liver is always present and strictly related to insulin resistance which, in the presence of severe liver steatosis, is also related to serum ferritin.
authors.affiliation: Interuniversity Center for Obesity and Eating Disorders, Department of Clinical and Experimental Medicine, Federico II University, Napoli, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Colicchio
authors.forename: G
authors.initials: G
authors.lastname: Tarantino
authors.forename: F
authors.initials: F
authors.lastname: del Genio
authors.forename: P
authors.initials: P
authors.lastname: Sorrentino
authors.forename: G
authors.initials: G
authors.lastname: Saldalamacchia
authors.forename: C
authors.initials: C
authors.lastname: Finelli
authors.forename: P
authors.initials: P
authors.lastname: Conca
authors.forename: F
authors.initials: F
authors.lastname: Contaldo
authors.forename: F
authors.initials: F
authors.lastname: Pasanisi
mesh_terms: D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D015992:Body Mass Index; D005234:Fatty Liver / Q000097:blood / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D005293:Ferritins / Q000097:blood*; D006801:Humans; D007333:Insulin Resistance; D007558:Italy / Q000453:epidemiology; D008099:Liver / Q000000981:diagnostic imaging / Q000201:enzymology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000097:blood / Q000150:complications* / Q000378:metabolism; D015995:Prevalence; D012720:Severity of Illness Index; D012737:Sex Factors; D000637:Transaminases / Q000097:blood*; D014463:Ultrasonography
chemical_list: D005293:Ferritins; D000637:Transaminases; D000410:Alanine Transaminase